haki_whārangi

Ngā Pūrongo

Tō Aratohu ki te Hoko i te Paura Oleoylethanolamide Kounga

Kei te rapu koe i tētahi kaiwhakarato paura Oleoylethanolamide (OEA) kounga teitei? Nā ōna painga pea mō te whakahaere taumaha me te hauora whānui, kāore he mea miharo he tokomaha te hunga e hiahia ana ki tēnei matū. Heoi, i te wā e hoko ana koe i te paura OEA, he mea nui kia whakarite kei te whiwhi koe i tētahi hua kounga teitei e tutuki ai ō hiahia. Nō reira, me whai whakaaro nui ki te kaiwhakarato, te parakore, te kaha, te āhua, me te utu hei hoko i te paura oleoylethanolamide kounga teitei. Mā te whakaaro ki ēnei āhuatanga me te rapu tohutohu ngaio, ka taea e koe te whakatau whai whakaaro me te whiriwhiri ki te tautoko i tō pakihi me te paura OEA kounga teitei.

He aha te OEA i roto i ngā kupu hauora?

 

I roto i te ao hauora, he tini ngā kupu whakarāpopoto me ngā kupu e whakapoauau ana i te hunga kāore i te mōhio ki tēnei ao. Tērā pea he tokomaha kāore i te mōhio ki tēnei kupu:Oleylethanolamide (OEA)He aha rawa te OEA mai i te tirohanga hauora? He aha te mea nui kia mārama ki tēnei?

Kia mārama tātou ki te hanganga me ngā āhuatanga o te OEA!

Hanganga

Ko te ethanolamide waikawa oleic, ko te Oleoylethanolamide rānei (OEA), he mema nō ngā cannabinoids taketake. He matū amide tuarua tēnei i hangaia mai i te waikawa oleic lipophilic me te ethanolamine hydrophilic. He ngota lipid tūturu anō hoki te OEA i roto i ētahi atu kiko kararehe me ngā kiko tipu. He whānuitia te kitea i roto i ngā kiko kararehe me ngā kiko tipu pērā i te paura koko, te pīni soya, me ngā nati, engari he tino iti te ihirangi. Mēnā ka huri te taiao o waho, ka whakaohokia rānei te kai, ka nui ake te hanga o ngā kiko pūtau o te tinana. Ko reira anake ka nui ake te hanga o tēnei matū.

Taiao

I te pāmahana rūma, he totoka mā te OEA, ā, ko te ira rewa o te 50°C pea. He ngāwari te wairewa i roto i ngā whakarewa waipiro pērā i te methanol me te ethanol, he ngāwari ake te wairewa i roto i ngā whakarewa kore-polar pērā i te n-hexane me te ether, ā, kāore e wairewa i roto i te wai. He ngota amphiphilic te OEA e whakamahia ana hei surfactant me te hopi horoi i roto i te umanga matū. Heoi, i kitea e ētahi atu rangahau ka taea e te OEA te mahi hei ngota tohu lipid i roto i te tuaka puku-roro, ā, ka whakaatu i te raupapa o ngā mahi koiora i roto i te tinana, tae atu ki: te whakahaere i te hiahia kai, te whakapai ake i te pākia o te lipid, te whakarei ake i te mahara me te hinengaro me ētahi atu mahi. I roto i ēnei, ko ngā mahi a te OEA ki te whakahaere i te hiahia kai me te whakapai ake i te pākia o te lipid te mea i aro nuitia.

Ko te Oleylethanolamide (OEA) he matū ngako tūturu i hangaia i roto i te whekau iti. Nō roto i tētahi akomanga o ngā matū e mōhiotia ana ko ngā endocannabinoids. Ko te Oleoylethanolamide (OEA) i hangaia i roto i te tinana he ngota ngako tūturu e whai wāhi nui ana ki ngā tukanga tinana maha i roto i te tinana. Kua whakarōpūtia hei lipid bioactive, ā, he wāhanga o te pūnaha endocannabinoid, he whatunga matatini o ngā ngota tohu me ngā kaiwhakawhiwhi e whai wāhi ana ki te whakahaere i ngā mahi maha o te tinana, tae atu ki te hiahia kai, te pākia o te kai, te mamae, me te mumura.

Ka taea e te OEA te whakahaere i te kai e kainga ana me te homeostasis pūngao mā te whakahohe i te receptor-α kua whakahohehia e te peroxisome proliferator. Hei tāpiri, kei te whakaatu te OEA i ētahi atu mahi e pā ana ki te hauora, tae atu ki te whakarerekē i te mahi kaitahuri i roto i te ara tohu lysosomal-ki-nuclear e pā ana ki te whakahaere i te roa o te ora me te tiaki i ngā io e whakahaere ana i ngā whanonga pouri.

E whakaatu ana hoki ngā rangahau hou he pānga tiaki io ​​pea te OEA. I roto i ngā tauira kararehe, kua kitea ka whakaitihia e ia te kino mai i te whiu me te whara roro.

Ko te pānga whakahaere o te OEA e pā ana ki tōna herenga ki te PPARα, e whakawhāiti ana ki te retinoid X receptor (RXR) ka whakahohe i a ia hei take whakawhitiwhiti kaha e uru ana ki te homeostasis pūngao whakakotahi, te pākia o te ngako, te autophagy, me te mumura.

Heoi, he tino iti te ihirangi OEA, ā, he uaua ki te tiki tika mai i ngā puna kai, nō reira me whakawhanake ētahi atu puna OEA. I roto i ēnei, ko te hanga matū me ngā tauhohenga whakawhiti koiora ngā puna o nāianei mō te whiwhi OEA. I roto i ēnei, ka whakaputa a Suzhou Mailun Biotechnology i te OEA kounga teitei, parakore mā te hanga matū.

Ko te tukanga hanga o te OEA e rua ngā tukanga matua: te hanga o te N-oleoylphosphatidylethanolamine (NOPE) i ahu mai i te phospholipid me te hurihanga o te NOPE ki te OEA. Ko te shunt o te NAS, te NAT rānei, e whai wāhi ana ki te hanganga o te NOPE, ā, ka taea te whakaputa i te OEA mā roto i ngā ara maha, ko te phospholipase D (PLD) te ara tino tika.

Paura Oleoylethanolamide2

He aha te rerekētanga i waenga i te pī me te OEA?

PEA, whakarāpopototanga mōPalmitoylethanolamide (PEA), he waikawa ngako amida e hangaia ana e te tinana hei whakautu ki te mumura me te mamae. Ka kitea hoki i roto i ētahi kai, inā koa ko ērā he nui ngā ngako hauora pēnei i te hua manu, te pīni soya, me te pīnati. Kua rangahauhia te PEA mō ōna pānga ārai-mumura me te whakamamae mamae, ā, he mea rongonui hei tāpiringa mō te hunga e pāngia ana e te mamae mau tonu, te mate rumatiki, me ētahi atu mate mumura.

Ko te OEA (oleoylethanolamide rānei), i tētahi atu ringa, he ngota lipid e hangaia ana i roto i te whekau iti. Ko tana mahi matua he whakahaere i te hiahia me te taumaha o te tinana mā te taunekeneke ki te pūnaha endocannabinoid. E mōhiotia ana mō tōna kaha ki te whakatairanga i te makona me te whakaiti i te kai e kainga ana, ko te Oleoylethanolamide (OEA) he kōwhiringa whai hua mō te hunga e rapu ana ki te tautoko i te whakahaere taumaha me ngā tikanga kai hauora.

Ko tētahi o ngā rerekētanga matua i waenga i te PEA me Oleoylethanolamide(OEA) ko tā rātou tikanga mahi me ngā pūnaha o te tinana e arohia ana e rātou. Ko te mahi nui a te PEA ko ngā ara mumura me te kite mamae, ko te OEA ia e aro ana ki te whakahaere i te hiahia me te taurite pūngao. He mea nui tēnei rerekētanga ina whakaarohia ngā painga pea o ia matū me te pehea e taea ai te whakamahi hei whakatika i ngā raruraru hauora motuhake.

Mō ngā painga hauora pea, kua rangahaua te PEA mō tana mahi ki te rongoā i te mamae mau tonu pērā i te fibromyalgia, te neuropathy, me te sciatica. Nā ōna āhuatanga ārai-mumura, he mea nui tēnei hei whiringa mā te hunga e rapu ana i tētahi huarahi tūturu hei whakakapi i ngā rautaki whakahaere mamae tuku iho. Hei tāpiri, e whakaatu ana te PEA i te pūmanawa ki te tautoko i te hauora kiri me te mahi ārai mate, me te whakawhānui ake i ōna tono pea ki te whakatairanga i te hauora whānui.

I tētahi atu taha, kua arohia te mahi a te Oleoylethanolamide (OEA) ki te whakahaere i te hiahia kai me te whakahaere taumaha hei aro atu ki te momona me ngā mate pāwera. E whakaatu ana ngā rangahau ka āwhina pea te Oleoylethanolamide (OEA) ki te whakahaere i ngā hiahia kai, te whakaiti i te kai nui, me te tautoko i te pāwera hauora, ka waiho hei taputapu whai hua mō ngā tāngata e whai ana ki te whakatutuki me te pupuri i te taumaha hauora. Hei tāpiri, ko te taunekeneke a te OEA me te pūnaha endocannabinoid e whakaatu ana i tōna pānga pea ki te wairua me ngā whanonga kai kare ā-roto.

Ahakoa he rerekē ngā pānga me ngā painga pea o te Palmitoylethanolamide (PEA) me te Oleoylethanolamide (OEA), he mea nui kia mōhio kāore rāua e tū motuhake tetahi ki tetahi. Inaa, tera pea ka kitea e ētahi tāngata he uara te whakauru i ngā matū e rua ki roto i ā rātou tikanga hauora hei aro atu ki ngā āhuatanga maha o tō rātou hauora. Hei tauira, ko te hunga e pāngia ana e te mamae mau tonu me ngā raruraru whakahaere taumaha ka whai hua pea i ngā āhuatanga anti-inflammatory o te PEA me ngā pānga whakahaere hiahia o te OEA.

Paura Oleoylethanolamide1

Ngā Hua o te Paura Oleoylethanolamide

Te Whakahaere i te Hiahia me te Whakahaere Taumaha

I ngā tau tata nei, kua piki haere te rongonui o te oleoylethanolamide hei tāpiringa kai mō te whakaiti taumaha. E whakaatu ana ngā rangahau ka taea e te OEA te āwhina i te whakaiti i te hiahia kai, ka heke ai te kai me te whakaheke taumaha i muri mai.

He mea nui te OEA hei aukati i te kai e kainga ana, ā, ko tana mahi matua he āwhina i te whakaiti i te momona. Mā te werohanga OEA ki roto i te puku ka taea te whakaiti i te kai e kainga ana me te whakanui i te taumaha o ngā kiore. Ko te pānga matua o te OEA ki te whakaheke taumaha ko te whakaputa i te mākona, ā, mā reira ka whakahaere i te kai nui rawa. Mā te tāpiri i tētahi kukū o te OEA ki te kai a ngā kiore noa, momona rānei, ka taea te whakaiti i te hiahia me te taumaha o ngā kiore.

Kāore e taea e te OEA te aukati i te mimiti ngako puku anake, engari ka tere ake hoki te waikura beta o ngā waikawa ngako mā te whakatairanga i te waikura o ngā triglycerides i roto i ngā kiko taha (ate me te ngako), ā, ka mutu ka whakaitihia te kohikohinga ngako me te whakatutuki i te whakahaere taumaha.

Hei tāpiritanga, ka mahi te OEA ki ngā kaiwhakawhiwhi PPAR i roto i te whekau iti, ka āwhina ki te whakaiti i te hiahia kai me te whakanui ake i te pakaru o te ngako i roto i te tinana. Ko te hua o tēnei pānga pākia o te OEA ka piki ake te whakapaunga pūngao, he mea nui mō te whakaheke taumaha.

Haunga te whakahaere i te hiahia kai, ka tautoko te paura OEA i te pūnaha io hauora. E whakaatu ana ngā rangahau ka āwhina pea te OEA ki te whakanui ake i te whakapaunga pūngao o te tinana, ka piki ake pea te tere o te pūnaha io. Mā te whakatairanga i te lipolysis me te whakapai ake i te whakamahinga pūngao, ka taea e te paura OEA te tautoko i te hunga e hiahia ana ki te pupuri i te taumaha me te pūnaha io hauora.

Te whakahaere i te kare ā-roto me te ahotea

Kua whakaatuhia te whai huatanga o te Oleoylethanolamide (OEA) ki te whakaiti i te ahotea me te manukanuka i roto i te tinana. Ka āwhina te OEA ki te whakahaere i te whakaputanga o ngā homoni ahotea pēnei i te cortisol, ā, ka whakaiti i te manukanuka me te ahotea.

E whakaatu ana ngā rangahau ka āwhina te OEA ki te whakahohe i ngā kaiwhakawhiwhi PPAR i roto i te amygdala, te wāhanga o te roro e whakahaere ana i te manukanuka me te ahotea. Mā tēnei whakahohenga ka heke te ahotea me te manukanuka. Ka āwhina ki te whakaiti i te manukanuka me te whakatairanga i te oranga ngākau.

I tua atu, kua honoa te OEA ki te whakahaere i ngā taumata dopamine i roto i te roro, ka taea e ia te whai wāhi ki te whakahaere i te wairua me te hauora hinengaro whānui.

 Te mumura me te mahi ārai mate

E hono ana te mumura mau tonu ki ngā momo raruraru hauora, tae atu ki te momona, te mate huka me ngā mate pūnaha toto. Kua whakaatuhia te āwhina a te Oleoylethanolamide (OEA) ki te whakaiti i te mumura i roto i te tinana.

E whakaatu ana ngā rangahau ka āwhina te OEA ki te whakaiti i te hanga o ngā cytokine, arā, ngā tohu o te mumura i roto i te tinana. Ka āwhina hoki te OEA ki te whakaiti i te ahotea waikura, he tino take o te mumura i roto i te tinana.

He pai te mahi a te Oleoylethanolamide (OEA) ki te whakahaere i ngā urupare mumura i roto i te tinana, ka pā pea tēnei ki te mahi ārai mate whānui me te ārai i ngā mate. Ka taea e te paura Oleoylethanolamide (OEA) te whakarato i ngā painga hauora mō te wā roa mā te tautoko i tētahi urupare mumura hauora.

Ka whakaiti i ngā ngako toto me te ātete ki te atherosclerosis

Ko te kaiwhakawhiwhi-α e whakahohehia ana e te peroxisome proliferator (PPAR-α) he momo kaiwhakawhiwhi e pā tata ana ki ngā mahi pākia o te tinana. Ka whai wāhi te PPAR-α ki te pākia o te ngako mā te herea ki te huānga urupare peroxisome proliferator. Ko te kawe pākia, te whakahaere ārai mate, te ārai mumura, te ārai tipu me ētahi atu tukanga e pā ana ka whai wāhi anō ki te whakahaere i ngā ngako toto me te ārai i te atherosclerosis.

Ko te Oleoylethanolamide (OEA) he rite ki te endocannabinoid ka puta ina whakaohokia ngā kiko o te tinana. Kua whakaatuhia e ngā rangahau ka whakahohe te OEA i te PPAR-M, ka whakaiti i te tukunga o te endothelin-1, ka aukati i te vasoconstriction me te tipu o ngā pūtau uaua maeneene, ka whakatairanga i te vasodilation, ā, i te wa ano ka whakanui ake i te hanganga o te endothelial nitric oxide synthase me te whakaoho i te hanga o te nitric oxide synthase. hauota, nā reira ka whakaitihia te hanga o ngā ngota piri pūtau vascular, ka tutuki ngā pānga anti-inflammatory, me te whakaatu i ngā pānga o te whakaheke i ngā lipids toto me te anti-atherosclerosis.

 Te hauora o te roro me te mahi hinengaro

E ai ki ngā rangahau, tera pea he pānga o te paura OEA ki te hauora o te roro me te mahi hinengaro. Kua whakaaturia te kaha o te Oleoylethanolamide (OEA) ki te whiti i te arai toto-roro me te taunekeneke ki ngā kaiwhakawhiwhi i roto i te roro, ka hua ake he pānga pea ki te mahi hinengaro me te tiaki io.

He mea tika kia whakahuatia ko te OEA ka pā ki te haere whakamua o te AD. Ko te mate amyloid-beta (Aβ) o te mate a Alzheimer (AD) ka haere tahi me ngā huringa nui o ngā pūtau glial i roto i te roro. Kua whakaatuhia e ngā rangahau hononga whānui-ira he mea nui te mahi a te microglia me ō rātou ara e pā ana, pērā i te phagocytosis, te pākia o te lipid, me te urupare ārai mate, i roto i te pūtake o te AD tīmatanga-mutunga.

Ko te Oleylethanolamine (OEA) he ngota ngako taketake kua tiakina i roto i te whanaketanga, kua whakaatuhia hei whakaroa i te roanga o te ora me te roanga hauora i roto i te C. elegans. I roto i ngā kararehe whakangote, ka puta te OEA i roto i ngā kiko taha me te pūnaha io matua, ā, i whakaatuhia e tētahi rangahau lipidomics kua tino heke te OEA me ētahi atu waikawa ngako ethanolamine i roto i te wai cerebrospinal me te plasma o ngā tūroro AD, e tohu ana ko ngā ngota pēnei i te OEA ka pā ki te haere whakamua o te AD.

Paura Oleoylethanolamide3

He Aratohu mō te Hokonga i te Paura Oleoylethanolamide Kounga

 

1. Kia mōhio ki te pūtake me te parakore

I te hoko i te paura Oleoylethanolamide (OEA), me whakaaro koe ki te pūtake me te parakore o te hua. Rapua ngā kaiwhakarato rongonui e whakamahi ana i ngā kai kounga teitei, e whai ana hoki i ngā paerewa hanga tino pakari. Ko te mea pai, me ahu mai te paura OEA i ngā pūtake taiao me te parakore teitei kia pai ai tōna whai huatanga me tōna haumaru.

2. Tirohia mēnā he whakamātautau a te hunga tuatoru

Hei whakarite i te kounga me te parakore o te paura Oleoylethanolamide (OEA), he mea nui kia whiriwhiria ngā hua kua whakamatautauria e ngā taiwhanga tuatoru. Mā te whakamātautau tuatoru ka whakarite kia kore he poke o ngā paura OEA, ā, ka tutuki i ngā taumata kaha me te parakore kua tohua. Rapua ngā hua e whakarato ana i ngā hua whakamātautau mārama me te manatoko, kia marino ai tō hinengaro mō te kounga o te paura OEA e hokona ana e koe.

3. Whakaarohia te tunu

Kei te wātea te paura Oleoylethanolamide (OEA) i roto i ngā momo hanganga, tae atu ki ngā kāpū me ngā paura. I te wā e whiriwhiri ana i tētahi hanganga e tika ana māu, whakaarohia ō hiahia me tō momo noho. Ka whakaratohia e ngā kāpū he inenga watea me te tika, engari ka taea te whakaranu ngāwari i ngā paura me ngā wai ki roto i ngā inu, i ngā kai rānei.

4. Aromatawai i te ingoa o te kaiwhakarato

I te hoko paura OEA, he mea nui kia hoko mai i tētahi kaiwhakarato whai ingoa me te pono. Rangahauhia te ingoa o tētahi kaiwhakarato, ngā arotake a ngā kiritaki, me ngā tiwhikete kia tino mohio ai koe kei te whiwhi koe i tētahi hua pono me te kounga teitei. Ka mārama te kaiwhakarato whai ingoa mō ā rātou puna, ngā tukanga hanga, me te kounga o te hua, ka hoatu he whakapono ki a koe i roto i tāu hoko.

5. Aromatawaihia te utu me te uara

Ahakoa ehara te utu i te mea whakatau anake, he mea nui kia whakaarohia te uara o te paura OEA e hokona ana e koe. Whakatauritehia ngā utu mai i ngā kaiwhakarato rerekē, me te whakaaro ki te takenga mai o te hua, te parakore, te hanganga me te rongonui. Kia maumahara he nui ake te utu o te paura OEA kounga teitei, engari he pai te haumi ki te uara e whakaratohia ana e ia i runga i te whai huatanga me te haumaru.

6. Kōrero ki tētahi tohunga hauora

I mua i te tāpiri i te paura OEA ki tō kai tāpiringa, he mea pai kia kōrero koe ki tētahi tohunga hauora, inā koa mēnā he mate hauora tōu, kei te tango rongoā rānei koe. Ka taea e te tohunga hauora te tuku tohutohu whaiaro me te whakarite kia tika te OEA mō tō hauora o ia rā.

Paura Oleoylethanolamide4

Kei hea te hoko i te paura oleoylethanolamide me te haumaru

 

Kua ngaro ngā rā i kore ai koe i te mōhio ki hea e hoko ai i te Oleoylethanolamide (OEA). He tino pukumahi te mahi a taua wā. Me haere koe i ia toa ki ia toa, ki ngā hūpāmakete, ki ngā toa hokohoko, ki te pātai mō āu tāpiringa tino pai. Ko te mea kino rawa atu ka pā mai ko te hikoi haere i te rā katoa, ā, kāore e whiwhi i tāu e hiahia ana. Ko te mea kino rawa atu, ki te whiwhi koe i tēnei hua, ka pēhia koe ki te hoko i taua hua.

I ēnei rā, he maha ngā wāhi hei hoko paura Oleoylethanolamide (OEA). Nā te ipurangi, ka taea e koe te hoko i ngā mea katoa me te kore e wehe atu i tō kāinga. Ehara i te mea ka māmā ake tō mahi mā te ipurangi, engari ka watea ake hoki tō wheako hokohoko. Kei a koe anō te whai wāhi ki te pānui atu mō tēnei tāpiringa whakamiharo i mua i te whakatau ki te hoko.

He maha ngā kaihoko ipurangi i ēnei rā, ā, tera pea he uaua ki a koe te whiriwhiri ko tēhea te mea pai rawa atu. Ko te mea me mōhio koe, ahakoa ka oati katoa rātou i te koura, kāore e tutuki katoa.

Ki te hiahia koe ki te hoko nui i te paura Oleoylethanolamide (OEA), ka taea e koe te whakawhirinaki mai ki a mātou. Kei a mātou ngā tāpiringa pai rawa atu hei whakatutuki i ngā hua. Tonoa mai i Suzhou Myland Pharm i tēnei rā, ā, tīmatahia tō haerenga ki te hauora pai rawa atu.

Kua uru atu a Suzhou Myland Pharm & Nutrition Inc. ki te pakihi tāpiringa kai mai i te tau 1992. Koinei te kamupene tuatahi i Haina ki te whakawhanake me te hokohoko i te tangohanga kākano karepe.

Me te 30 tau o te wheako, ā, e ārahihia ana e te hangarau matatau me te rautaki R&D tino arotau, kua whakawhanakehia e te kamupene he whānuitanga o ngā hua whakataetae, ā, kua riro hei kamupene auaha mō ngā tāpiringa pūtaiao koiora, te hanga ritenga me ngā ratonga hanga.

Hei tāpiritanga, ko Suzhou Myland Pharm & Nutrition Inc. tētahi kaihanga kua rēhitatia ki te FDA. He hou, he maha ngā mahi a ngā rauemi R&D a te kamupene, ngā whare whakaputa, me ngā taputapu tātari, ā, ka taea te whakaputa matū mai i te mirikaramu ki te tana i te tauine, me te tutuki i ngā paerewa ISO 9001 me ngā whakaritenga whakaputa GMP.

 

P: He aha te paura Oleoylethanolamide (OEA) me pēhea tana mahi?
A: Ko te paura Oleoylethanolamide (OEA) he ngota ngako tūturu e hangaia ana i roto i te whekau iti. Ka mahi mā te whakahohe i te peroxisome proliferator-activated receptor alpha (PPAR-α), e whai wāhi ana ki te whakahaere i te pākia o te kai me te whakatairanga i te mākona.

Q: He aha ngā painga pea o te whakamahi i te paura Oleoylethanolamide (OEA)?
A: Ko ētahi o ngā painga pea o te whakamahi i te paura OEA ko te pehi i te hiahia kai, te whakahaere taumaha, me te tautoko i te hauora o te pākia o te tinana. Tērā pea he āhuatanga ārai-mumura me te tiaki io ​​hoki.

P: Me pēhea taku whiriwhiri i te paura Oleoylethanolamide (OEA) kounga teitei?
A: I te wā e whiriwhiri ana i te paura OEA, he mea nui kia rapu i tētahi kaiwhakarato rongonui e whakarato ana i ngā whakamātautau tuatoru mō te parakore me te kaha. Hei tāpiri, whakaarohia te pūtake o te paura, me te whiriwhiri i ngā hua i ahu mai i ngā pūtake taiao, pumau.

Whakakape: He kōrero whānui noa iho tēnei tuhinga, kaua e whakamāramatia he tohutohu hauora. Ko ētahi o ngā kōrero o te pou rangitaki i ahu mai i te Ipurangi, ehara i te mea ngaio. Ko tā tēnei paetukutuku anake he whakarōpū, he whakatakotoranga me te whakatika i ngā tuhinga. Ko te kaupapa o te kawe atu i ētahi atu kōrero, ehara i te mea e whakaae ana koe ki ōna tirohanga, e whakaū ana rānei i te pono o ōna ihirangi. Me kōrero tonu ki tētahi tohunga hauora i mua i te whakamahi i tētahi tāpiringa, i te hanga rānei i ngā huringa ki tō tikanga tiaki hauora.


Wā tuku: 23 o Ākuhata-2024